Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 1
1953 1
1956 1
1957 1
1959 1
1960 4
1961 2
1963 2
1964 5
1965 4
1966 10
1967 4
1968 11
1969 24
1970 22
1971 22
1972 18
1973 28
1974 32
1975 53
1976 66
1977 83
1978 70
1979 76
1980 81
1981 88
1982 71
1983 99
1984 117
1985 120
1986 121
1987 137
1988 147
1989 213
1990 189
1991 233
1992 300
1993 315
1994 243
1995 277
1996 397
1997 498
1998 500
1999 501
2000 488
2001 470
2002 509
2003 554
2004 623
2005 715
2006 879
2007 822
2008 945
2009 964
2010 977
2011 1092
2012 1217
2013 1253
2014 1326
2015 1400
2016 1555
2017 1529
2018 1578
2019 1744
2020 1990
2021 2107
2022 1980
2023 1720
2024 759

Text availability

Article attribute

Article type

Publication date

Search Results

30,166 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Cataract 50 with or without glaucoma"
Page 1
The pathophysiology and treatment of glaucoma: a review.
Weinreb RN, Aung T, Medeiros FA. Weinreb RN, et al. JAMA. 2014 May 14;311(18):1901-11. doi: 10.1001/jama.2014.3192. JAMA. 2014. PMID: 24825645 Free PMC article. Review.
IMPORTANCE: Glaucoma is a worldwide leading cause of irreversible vision loss. ...OBJECTIVE: To describe current evidence regarding the pathophysiology and treatment of open-angle glaucoma and angle-closure glaucoma. EVIDENCE REVIEW: A literature search was c …
IMPORTANCE: Glaucoma is a worldwide leading cause of irreversible vision loss. ...OBJECTIVE: To describe current evidence regarding t …
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.
GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. GBD 2019 Blindness and Vision Impairment Collaborators, et al. Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1. Lancet Glob Health. 2021. PMID: 33275949 Free PMC article.
Because of data sparsity at younger ages, our analysis focused on adults aged 50 years and older. FINDINGS: Global crude prevalence of avoidable vision impairment and blindness in adults aged 50 years and older did not change between 2010 and 2019 (percentage change …
Because of data sparsity at younger ages, our analysis focused on adults aged 50 years and older. FINDINGS: Global crude prevalence o …
Glaucoma: now and beyond.
Jayaram H, Kolko M, Friedman DS, Gazzard G. Jayaram H, et al. Lancet. 2023 Nov 11;402(10414):1788-1801. doi: 10.1016/S0140-6736(23)01289-8. Epub 2023 Sep 21. Lancet. 2023. PMID: 37742700 Review.
The glaucomas are a group of conditions leading to irreversible sight loss and characterised by progressive loss of retinal ganglion cells. ...It remains the leading cause of irreversible blindness, but timely treatment to lower intraocular pressure is effective at slowing …
The glaucomas are a group of conditions leading to irreversible sight loss and characterised by progressive loss of retinal ganglion …
Approach to childhood glaucoma: A review.
Karaconji T, Zagora S, Grigg JR. Karaconji T, et al. Clin Exp Ophthalmol. 2022 Mar;50(2):232-246. doi: 10.1111/ceo.14039. Epub 2022 Jan 25. Clin Exp Ophthalmol. 2022. PMID: 35023613 Review.
It can be classified as either primary or secondary and the latter may have systemic associations. This review will be based on the work of the childhood glaucoma research network (CGRN) and will focus on the diagnosis and management of the most common types of childhood …
It can be classified as either primary or secondary and the latter may have systemic associations. This review will be based on the work of …
The Complications of Myopia: A Review and Meta-Analysis.
Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW. Haarman AEG, et al. Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):49. doi: 10.1167/iovs.61.4.49. Invest Ophthalmol Vis Sci. 2020. PMID: 32347918 Free PMC article.
PURPOSE: To determine the risk between degree of myopia and myopic macular degeneration (MMD), retinal detachment (RD), cataract, open angle glaucoma (OAG), and blindness. METHODS: A systematic review and meta-analyses of studies published before June 2019 on myopia …
PURPOSE: To determine the risk between degree of myopia and myopic macular degeneration (MMD), retinal detachment (RD), cataract, ope …
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.
Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR; Vision Loss Expert Group of the Global Burden of Disease Study. Flaxman SR, et al. Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5. Epub 2017 Oct 11. Lancet Glob Health. 2017. PMID: 29032195 Free article. Review.
Among the global population who were blind in 2015 (36.0 million [12.9 million to 65.4 million]), the leading causes were cataract (12.6 million [3.4 million to 28.7 million]), uncorrected refractive error (7.4 million [2.4 million to 14.8 million]), and glaucoma (2 …
Among the global population who were blind in 2015 (36.0 million [12.9 million to 65.4 million]), the leading causes were cataract (1 …
Association of Behavioral and Clinical Risk Factors With Cataract: A Two-Sample Mendelian Randomization Study.
Jiang C, Melles RB, Sangani P, Hoffmann TJ, Hysi PG, Glymour MM, Jorgenson E, Lachke SA, Choquet H. Jiang C, et al. Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):19. doi: 10.1167/iovs.64.10.19. Invest Ophthalmol Vis Sci. 2023. PMID: 37459064 Free PMC article.
PURPOSE: To investigate the association of genetically determined primary open-angle glaucoma (POAG), myopic refractive error (RE), type 2 diabetes (T2D), blood pressure (BP), body mass index (BMI), cigarette smoking, and alcohol consumption with the risk of age-related …
PURPOSE: To investigate the association of genetically determined primary open-angle glaucoma (POAG), myopic refractive error (RE), t …
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.
GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. GBD 2019 Blindness and Vision Impairment Collaborators, et al. Lancet Glob Health. 2021 Feb;9(2):e130-e143. doi: 10.1016/S2214-109X(20)30425-3. Epub 2020 Dec 1. Lancet Glob Health. 2021. PMID: 33275950 Free PMC article.
We estimated 295 million (267-325) people to have moderate and severe vision impairment, of whom 163 million (55%; 147-179) were female; 258 million (233-285) to have mild vision impairment, of whom 142 million (55%; 128-157) were female; and 510 million (371-667) to have visual …
We estimated 295 million (267-325) people to have moderate and severe vision impairment, of whom 163 million (55%; 147-179) were female; 258 …
Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm's Canal Microstent in Combination Cataract and Glaucoma Surgery.
Ahmed IIK, De Francesco T, Rhee D, McCabe C, Flowers B, Gazzard G, Samuelson TW, Singh K; HORIZON Investigators. Ahmed IIK, et al. Ophthalmology. 2022 Jul;129(7):742-751. doi: 10.1016/j.ophtha.2022.02.021. Epub 2022 Feb 23. Ophthalmology. 2022. PMID: 35218867 Clinical Trial.
DESIGN: Prospective, multicenter, controlled randomized clinical trial. PARTICIPANTS: Patients with cataract and primary open-angle glaucoma treated with 1 or more glaucoma medications, washed-out diurnal intraocular pressure (DIOP) of 22 to 34 mmHg, and no p …
DESIGN: Prospective, multicenter, controlled randomized clinical trial. PARTICIPANTS: Patients with cataract and primary open-angle …
The glaucomas.
Coleman AL, Brigatti L. Coleman AL, et al. Minerva Med. 2001 Oct;92(5):365-79. Minerva Med. 2001. PMID: 11675580 Review.
Glaucoma is the leading cause of irreversible blindness worldwide. ...Primary (Chronic) Open Angle Glaucoma is the most common, with a prevalence in the USA of 1.55%. ...
Glaucoma is the leading cause of irreversible blindness worldwide. ...Primary (Chronic) Open Angle Glaucoma is the most common …
30,166 results
You have reached the last available page of results. Please see the User Guide for more information.